Cell and Gene Therapy Supply Chain/Logistics Market Study Analysis with Forecast to 2034

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cell and Gene Therapy Supply Chain/Logistics Market - (By Application Area (Donor eligibility assessment, Sample collection, Manufacturing, Logistics, Patient verification and treatment follow-up), By Type of Software Solution (Cell orchestration platform, Enterprise manufacturing system, Inventory management system, Laboratory information management system, Logistics management system, Patient management system, Quality management system, Tracking and tracing system), By End-User (Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization), By Type of Deployment (Cloud-Based, On-premises)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."

According to the latest research by InsightAce Analytic, the Global Cell and Gene Therapy Supply Chain/Logistics Market Size is valued at 1.5 Billion in 2024 and is predicted to reach 4.4 Billion by the year 2034 at a 11.9 % CAGR during the forecast period for 2025-2034.

Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1694

The global cell and gene therapy logistics market is rapidly evolving to accommodate the increasing demand for personalized medical treatments. Specialized supply chain solutions are being developed to support various stages of therapy, including patient identification, cell collection, therapeutic processing, and long-term outcome monitoring. As cell and gene therapies continue to revolutionize healthcare by offering tailored treatments for individual patients, the need for flexible and efficient supply chain services has never been greater.

The market's expansion is primarily driven by biotechnological advancements and the growing adoption of personalized medicine. The importance of cold chain logistics is becoming more pronounced as these therapies gain prominence in treating cancer, genetic disorders, and autoimmune diseases. However, the industry faces significant challenges due to the complex and fragmented supply chain.

List of Major Players in the Cell and Gene Therapy Supply Chain/Logistics Market:
• Be The Match BioTherapies
• MAK-SYSTEM
• Cryoport
• Brooks Life Sciences
• Lykan Bioscience
• Clarkston Consulting
• SAP
• Hypertrust Patient Data Care
• Haemonetics
• MasterControl
• TraceLink
• SAVSU Technologies
• TrakCel
• Title21 Health Solutions
• sedApta Group
• Vineti
• Stafa Cellular Therapy
• Thermo Fisher Scientific
• McKesson
• Biocair
• Marken
• Modality Solutions
• Almac
• Arvato Supply Chain Solutions SE
• Catalent, Inc
• BioLife Solutions, Inc
• Biostor Ltd
• Yourway Biopharma Services Company
• Atelerix Ltd
• Other Prominent Players

Market Dynamics:
Drivers
The increasing adoption of personalized therapies tailored to individual patient needs is significantly shaping the cell and gene therapy logistics market. These advanced treatments, particularly for rare and complex diseases, require sophisticated supply chain solutions to ensure seamless delivery. The rise in patient-centric approaches has heightened the demand for specialized logistics infrastructure, ensuring safe and efficient transport of delicate biological materials. Technological advancements, such as gene-editing innovations like CRISPR, are playing a crucial role in accelerating the development and distribution of cell and gene therapies. Additionally, regulatory support from agencies such as the FDA and EMA has facilitated faster approvals, paving the way for greater commercialization of these therapies.

Curious About This Latest Version Of The Report? Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/1694

Challenges
One of the primary challenges in the global cell and gene therapy logistics sector is the requirement for precise temperature control throughout the supply chain. The effectiveness and safety of these therapies heavily depend on maintaining strict temperature conditions during storage and transportation. Even minor fluctuations can compromise product integrity, rendering treatments ineffective or unsafe for patients.
Managing temperature-sensitive shipments over long distances or under varying environmental conditions presents logistical complexities. To address these challenges, cold chain logistics providers must employ advanced temperature monitoring devices, data loggers, and real-time tracking systems to ensure compliance.

Regional Trends:
North America is expected to hold a significant share of the cell and gene therapy supply chain and logistics market, with strong revenue growth and a high projected CAGR in the coming years. This growth is primarily driven by a well-established healthcare infrastructure, substantial investments in research and development (R&D), and an increasing demand for innovative therapeutic solutions. Additionally, the region benefits from the presence of leading biopharmaceutical firms and advanced technological capabilities, further solidifying its market dominance.

Recent Developments:
• In Oct 2024, McKesson Corporation announced the introduction of InspiroGeneTM by McKesson ("InspiroGene"), a specialized entity exclusively aimed at facilitating the commercialization of cell and gene therapies (CGTs). InspiroGene offers a scalable and adaptable array of services, supported by a seasoned leadership team, to assist manufacturers, payers, and providers in maneuvering through the intricate environment of CGT commercialization, thereby ensuring patient access to essential, transformative medicines.
• In June 2024, Cryoport, Inc. formed a strategic collaboration to provide biotechnology and pharmaceutical companies with fully integrated manufacturing and shipping services for regenerative medicine products to advance cell and gene treatments.

Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/1694

Segmentation of Cell and Gene Therapy Supply Chain/Logistics Market-
By Application Area-
• Donor eligibility assessment
• Sample collection
• Manufacturing
• Logistics
• Patient verification and treatment follow-up
By Type of Software Solution-
• Cell orchestration platform
• Enterprise manufacturing system
• Inventory management system
• Laboratory information management system
• Logistics management system
• Patient management system
• Quality management system
• Tracking and tracing system
By End-User-
• Biobank
• Cell Therapy Lab
• Hospital
• Research Institute
• Commercial Organization
By Type of Deployment-
• Cloud-Based
• On-premises
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Get More Information: @
https://www.insightaceanalytic.com/report/cell-and-gene-therapy-supply-chain-logistics-market/1694

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.

Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace

This release was published on openPR.